{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-013061","form_type":"8-K","ticker":"EBS","cik":"0001367644","company_name":"Emergent BioSolutions Inc.","filed_at":"2026-01-14T23:59:59+00:00","discovered_at":"2026-05-14T18:02:34.922974+00:00","generated_at":"2026-05-16T10:22:54.938281+00:00","sec_items":["7.01","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"low","headline":"Emergent BioSolutions CEO presents at J.P. Morgan Healthcare Conference; no new data","bullets":["CEO Joe Papa presented at the 44th Annual J.P. Morgan Healthcare Conference on January 14, 2026.","Investor slides furnished as Exhibit 99.1 contain no specific financial results or guidance updates.","No material business or operational changes disclosed in the filing or exhibit."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-013061","json":"https://secwatch.observer/filing/0001193125-26-013061.json","markdown":"https://secwatch.observer/filing/0001193125-26-013061.md","text":"https://secwatch.observer/filing/0001193125-26-013061.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1367644/000119312526013061/0001193125-26-013061-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1367644/000119312526013061/d921176d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T10:22:54.938281+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}